← Back to Analyst Consensus 
ABT Buy
ABBOTT LABORATORIES
Current Price —
Implied Upside —
Analysts 32
30-Day Momentum
▲ 3 upgrades / ▼ 0 downgrades / 9 reiterations from 10 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Wells Fargo | maintain | Overweight → Overweight | $120 | 54% |
| Oct 22, 2026 | Citigroup | maintain | Buy → Buy | $122 | 54% |
| Oct 22, 2026 | RBC Capital | maintain | Outperform → Outperform | $125 | 55% |
| Oct 22, 2026 | Wells Fargo | maintain | Overweight → Overweight | $119 | 54% |
| Oct 22, 2026 | JP Morgan | maintain | Overweight → Overweight | $118 | 54% |
| Oct 22, 2026 | TD Cowen | maintain | Buy → Buy | $118 | 54% |
| Oct 22, 2026 | Baird | maintain | Outperform → Outperform | $123 | 55% |
| Oct 22, 2026 | BTIG | maintain | Buy → Buy | $125 | 52% |
| Oct 16, 2026 | TD Cowen | reiterate | Buy → Buy | $135 | 54% |
| Oct 7, 2026 | Barclays | initiate | — → Overweight | $120 | 53% |
| Oct 2, 2026 | Rothschild & Co | upgrade | Neutral → Buy | $127 | 56% |
| Oct 2, 2026 | Rothschild& Co | upgrade | Neutral → Buy | $127 | — |
| Sep 8, 2026 | TD Cowen | reiterate | Buy → Buy | $135 | 54% |
| Aug 25, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 21, 2026 | TD Cowen | maintain | Buy → Buy | $135 | 54% |
| Aug 14, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 13, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $130 | 53% |
| Jul 28, 2026 | UBS | maintain | Buy → Buy | $125 | 54% |
| Jul 17, 2026 | Citigroup | maintain | Buy → Buy | $112 | 54% |
| Jul 17, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $118 | 54% |
| Jul 17, 2026 | JP Morgan | maintain | Overweight → Overweight | $120 | 54% |
| Jul 17, 2026 | Wells Fargo | maintain | Overweight → Overweight | $112 | 54% |
| Jul 17, 2026 | TD Cowen | reiterate | Buy → Buy | $115 | 54% |
| Jul 17, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $120 | 58% |
| Jul 17, 2026 | RBC Capital | reiterate | Outperform → Outperform | $130 | 55% |
| Jul 17, 2026 | BTIG | maintain | Buy → Buy | $134 | 52% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $112 | 58% |
| Jul 1, 2026 | Baird | initiate | — → Outperform | $121 | 55% |
| Jun 22, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| May 31, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 27, 2026 | BTIG | reiterate | Buy → Buy | $131 | 52% |
| Apr 20, 2026 | Barclays | maintain | Overweight → Overweight | $143 | 53% |
| Apr 17, 2026 | Piper Sandler | maintain | Overweight → Overweight | $115 | 54% |
| Apr 17, 2026 | Oppenheimer | maintain | Outperform → Outperform | $115 | 52% |
| Apr 17, 2026 | RBC Capital | maintain | Outperform → Outperform | $130 | 55% |
| Apr 17, 2026 | Benchmark | maintain | Buy → Buy | $120 | 54% |
| Apr 17, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $120 | 58% |
| Apr 17, 2026 | B of A Securities | maintain | Buy → Buy | $120 | 53% |
| Apr 17, 2026 | Stifel | maintain | Buy → Buy | $120 | 53% |
| Apr 17, 2026 | BTIG | reiterate | Buy → Buy | $131 | 52% |
| Apr 9, 2026 | Goldman Sachs | maintain | Buy → Buy | $121 | 54% |
| Apr 8, 2026 | Barclays | maintain | Overweight → Overweight | $144 | 53% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $134 | 58% |
| Mar 31, 2026 | BTIG | maintain | Buy → Buy | $131 | 52% |
| Mar 26, 2026 | Piper Sandler | maintain | Overweight → Overweight | $115 | 54% |
| Mar 11, 2026 | Citigroup | maintain | Buy → Buy | $136 | 54% |
| Feb 2, 2026 | Barclays | maintain | Overweight → Overweight | $142 | 53% |
| Jan 29, 2026 | Freedom Broker | upgrade | Hold → Buy | $120 | 59% |
| Jan 23, 2026 | Citigroup | maintain | Buy → Buy | $140 | 54% |
| Jan 23, 2026 | Bernstein | maintain | Outperform → Outperform | $125 | 52% |
Price Target Trend
Aug 23, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days